The involvement of CYP3A4 and CYP2C9 in the metabolism of 17α-ethinylestradiol

Drug Metabolism and Disposition

Volumn 32, Issue 11, 2004, Pages 1209-1212

  Wang, Bonnie ^a,b   Sanchez, Rosa I ^a   Franklin, Ronald B ^a   Evans, David C ^a   Huskey, Su Er W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; DRUG METABOLITE; ETHINYLESTRADIOL; KETOCONAZOLE; SULFAPHENAZOLE;

AEROBIC METABOLISM; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG METABOLISM; FEMALE; HUMAN; HUMAN CELL; LIVER MICROSOME; PRIORITY JOURNAL; WESTERN BLOTTING;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MICROSOMES, LIVER; NORETHYNODREL;

EID: 6944229545     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.000182     Document Type: Article

References (33)

1. Abdel-Aziz MT and Williams KI (1970) Metabolism of radioactive 17α-ethynylestradiol by women. Steroids 15:695-710.
2. Badawi AF, Cavalieri EL, and Rogan EG (2001) Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4- and 16alpha-hydroxylation of 17beta-estradiol. Metabolism 50:1001-1003.
3. Ball SE, Forrester LM, Wolf CR, and Back DJ (1990) Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes. Biochem J 267:221-226.
4. Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, and Flexner C (1999) The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clin Pharmacol Ther 65:428-438.
5. Bolt HM, Bolt M, and Kappus H (1977) Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. Acta Endocrinol 85:189-197.
6. Buchthal J, Grund KE, Buchmann A, Schrenk D, Beaune P, and Bock KW (1995) Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa. Eur J Clin Pharmacol 47:431-435.
7. Chen Y, Ferguson SS, Negishi M, and Goldstein JA (2004) Induction of human CYP2C9 by rifampicin, hyperforin and phenobarbital is mediated by the pregnane X receptor (PXR). J Pharmacol Exp Ther 308:495-501.
8. Ebner T, Remmel RP, and Burchell B (1993) Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol. Mol Pharmacol 43:649-654.
9. Finch CK, Chrisman CR, Baciewicz AM, and Self TH (2002) Rifampin and rifabutin drug interactions: an update. Arch Intern Med 162:985-992.
10. Forbes-Bamforth KJ and Coughtrie MW (1994) Identification of a new adult human liver sulfotransferase with specificity for endogenous and xenobiotic estrogens. Biochem Biophys Res Commun 198:707-711.
11. Guengerich FP (1988) Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450. Mol Pharmacol 33:500-508.
12. Guengerich FP (1990a) Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs. Am J Obstet Gynecol 163:2159-2163.
13. Guengerich FP (1990b) Metabolism of 17 alpha-ethynylestradiol in humans. Life Sci 47:1981-1988.
14. Guengerich FP (1997) Role of cytochrome P450 enzymes in drug-drug interactions. Adv Pharmacol 43:7-35.
15. Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, and Gorski JC (2003) The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther 74:525-535.
16. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, and Sutter TR (1996) 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93:9776-9781.
17. Kashfi K, McDougall CJ, and Dannenberg AJ (1995) Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human. Clin Pharmacol Ther 58:625-630.
18. Krausz KW, Goldfarb I, Buters JT, Yang TJ, Gonzalez FJ, and Gelboin HV (2001) Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9 and 2C19. Drug Metab Dispos 29:1410-1423.
19. Lasker JM, Wester MR, Aramsombatdee E, and Raucy JL (1998) Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin and omeprazole hydroxylations. Arch Biochem Biophys 353:16-28.
20. LeBel M, Masson E, Guilbert E, Colborn D, Paquet F, Allard S, Vallee F, and Narang PK (1998) Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone. J Clin Pharmacol 38:1042-1050.
21. Lee AJ, Kosh JW, Conney AH, and Zhu BT (2001) Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. J Pharmacol Exp Ther 298:420-432.
22. Lee AJ, Mills LH, Kosh JW, Conney AH, and Zhu BT (2002) NADPH-dependent metabolism of estrone by human liver microsomes. J Pharmacol Exp Ther 300:838-849.
23. Li AP, Hartman NR, Lu C, Collins JM, and Strong JM (1999) Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes. Br J Clin Pharmacol 48:733-742.
24. Orme ML, Back DJ, and Ball S (1989) Interindividual variation in the metabolism of ethynylestradiol. Pharmacol Ther 43:251-260.
25. Ouellet D, Hsu A, Qian J, Locke CS, Eason CJ, Cavanaugh JH, Leonard JM, and Granneman GR (1998) Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. Br J Clin Pharmacol 46:111-116.
26. Paine MF, Schmiedlin-Ren P, and Watkins PB (1999) Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazole. Drug Metab Dispos 27:360-364.
27. Rodrigues AD (1999) Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem Pharmacol 57:465-480.
28. Shou M, Korzekwa KR, Brooks EN, Krausz KW, Gonzalez FJ, and Gelboin HV (1997) Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis 18:207-214.
29. Towbin H, Staehelin T, and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
30. Williams MC and Goldzieher JW (1980) Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations. Steroids 36:255-281.
31. Williams MC, Helton ED, and Goldzieher JW (1975) The urinary metabolites of 17a-ethynylestradiol-9a,11xi-3H in women. Chromatographic profiling and identification of ethynyl and non-ethynyl compounds. Steroids 25:229-246.
32. Yamazaki H, Shaw PM, Guengerich FP, and Shimada T (1998) Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11:659-665.
33. Zhang QY, Dunbar D, Ostrowska A, Zeisloft S, Yang J, and Kaminsky LS (1999) Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos 27:804-809.